Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus

Ersoy, ALPARSLAN; Ersoy, C; Tekce, H; Yavascaoglu, I; Dilek, K

doi:10.1016/j.transproceed.2004.04.080

Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus

Ersoy A. , Ersoy C., Tekce H., Yavascaoglu I., Dilek K.

TRANSPLANTATION PROCEEDINGS, vol.36, no.5, pp.1407-1410, 2004 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 36 Issue: 5
Publication Date: 2004
Doi Number: 10.1016/j.transproceed.2004.04.080
Title of Journal : TRANSPLANTATION PROCEEDINGS
Page Numbers: pp.1407-1410

Abstract

Although drugs used in renal transplant recipients such as steroids, cyclosporine, and particularly, tacrolimus have diabetogenic potential, diabetic ketoacidosis is uncommon. There are few data concerning the long-term follow-up of these patients. Diabetic ketoacidosis occurred in a renal transplant recipient following de novo development associated with tacrolimus.